Quipt Home Medical Corp.·4

Mar 16, 9:39 AM ET

Bachelder David 4

Research Summary

AI-generated summary

Updated

Quipt (QIPT) Exec. VP David Bachelder Sells Shares

What Happened
David Bachelder, Executive Vice President of Operations at Quipt Home Medical Corp., disposed of shares on March 16, 2026 as part of a company sale/plan of arrangement. The Form 4 reports a disposition of 22,156 common shares at $3.65 each for $80,869 and two derivative dispositions (50,000 and 30,000 units) reported as N/A on the form. Footnotes to the filing state that all outstanding common shares, RSUs and vested/unvested options were cashed out under the arrangement at US$3.65 per share (less required tax withholdings), implying total gross consideration of approximately $372,869 for the 102,156 shares/units.

Key Details

  • Transaction date: March 16, 2026; reported on Form 4 filed March 16, 2026 (appears timely).
  • Reported trade(s): 22,156 common shares sold at $3.65 for $80,869; 50,000 and 30,000 derivative units (RSUs/options) disposed — Form lists N/A for per-unit price/value for these derivative items.
  • Post-transaction holdings: the filing does not state a remaining share count; footnotes indicate all Shares were deemed transferred to the purchaser under the arrangement.
  • Notable footnotes: (F1) Purchasers 1567208 B.C. LTD and REM Aggregator acquired all issued shares for US$3.65/share; (F2) RSUs were cashed out at US$3.65 each (less tax withholding); (F3) Options were vested/settled for the excess of US$3.65 over exercise price (options with exercise price ≥ US$3.65 cancelled).
  • Tax/withholding: cash consideration subject to required tax withholding per footnotes.

Context
These were not open-market sales but a cash-out of equity due to a going-private/arrangement transaction—common in acquisitions and not an ordinary insider sale reflecting trading sentiment. The derivative entries reflect RSUs/options being converted to cash under the deal rather than separate option exercises or market trades.